NCT05340634 2022-04-28Evaluation of Metionac for the Modulation of Metabolic and Endocrine Parameters in Patients With PCOS.Margan BiotechPhase 4 Completed90 enrolled
NCT01798875 2013-03-01PCOS, Therapy and Markers of Cardiovascular RiskMedical University of GdanskPhase 4 Unknown50 enrolled